IBM Plans to Increase Life Science Investment in 2001 | GenomeWeb

NEW YORK, Dec 18 – An IBM spokeswoman said Monday that the company intends to augment the $100 million life sciences initiative it launched in August to develop IT solutions for biotechnology, genomic, e-health, pharmaceutical, agri-science, and other life sciences industries.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.